Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Barrett Esophagus 6Stomach Neoplasms 4Gastritis 3Zollinger-Ellison Syndrome 2Stomach Ulcer 2Peptic Ulcer 2Esophageal Neoplasms 2Dyspepsia 2Colorectal Neoplasms 2Breast Neoplasms 2Precancerous Conditions 1Neoplasms 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastroesophageal Reflux 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis, Peptic 1Colonic Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Cyclophosphamide 282Rituximab 260Etoposide 161Filgrastim 155Vincristine 145Doxorubicin 134Prednisone 117Cytarabine 108Radiotherapy 102Peripheral Blood Stem Cell Transplantation 90Methotrexate 90fludarabine phosphate 87Melphalan 78Busulfan 71Dexamethasone 59Granulocyte Colony-Stimulating Factor 56Carmustine 53fludarabine 51Bortezomib 46Tacrolimus 44Mycophenolic Acid 41Antilymphocyte Serum 41Ifosfamide 40Leucovorin 39Gemcitabine 38Whole-Body Irradiation 36Cyclosporine 35Bendamustine Hydrochloride 34sargramostim 33Methylprednisolone 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma × Esomeprazole × Clear all
NCT01844583 2019-03-25

Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

Takeda

Phase 1 Completed
55 enrolled 29 charts
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡